Nifty Microcap 250

Sterlite Technologies has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bandhan Mutual Fund.

The above information is a part of company’s filings submitted to BSE.

Pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30th January, 2026 (SEBI Circular), Gujarat Ambuja Exports has informed that the Company has published advertisements in the English Newspaper -The Indian Express and in the Gujarati Newspaper -The Financial Express on 08th June, 2026. The said publications inform the Shareholders of the Company that a Special Window has been opened for transfer and dematerialisation of physical securities which were sold or purchased prior to 01st April, 2019. The said Special Window shall be available only for such instances and categories of cases as specifically provided under the SEBI Circular and shall remain open for eligible Shareholders from 05th February, 2026 to 04th February, 2027. The advertisement also requesting Members holding shares in physical form to furnish their PAN, Choice of Nomination, Contact details (Postal Address with PIN and Mobile Number), Bank A/c details and Specimen signature etc., to the RTA / Company and Members holding shares in demat form are requested to update their PAN, KYC and Choice of Nomination with their respective Depository Participants. Clipping of aforesaid Newspaper Advertisement are enclosed.

The above information is a part of company’s filings submitted to BSE.

In reference to the email dated June 8, 2026 in respect of clarification sought from for significant increase in the volume of Company’s security across Exchanges, in the recent past, Network 18 Media & Investments has informed that all disclosures which are required to be made in terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations). There is no disclosure that should have been made in terms of Listing Regulations and which has not been made by the Company. The company is aware of the obligations under Listing Regulations and will make disclosures in compliance with the said Regulations.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, Viyash Scientific has informed that, Alivira Animal Health Limited, Ireland, step-down wholly owned subsidiary of the Company, has entered into a binding agreement today i.e. June 8, 2026, for the acquisition of 100% shareholding of BioForLife Italia s.r.l., Milan, Italy. The aggregate consideration for the transaction is EUR 16.975 million, structured as follows: a. EUR 15.0 million payable at closing; and b. EUR 1.975 million as deferred consideration, in accordance with the terms of the transaction documents. The transaction is subject to fulfilment of the applicable conditions precedent and receipt of such statutory and regulatory approvals as are applicable to the transaction. The details required under Regulation 30 of the SEBI Listing Regulations read with the applicable SEBI circulars are enclosed as Annexure I.

The above information is a part of company’s filings submitted to BSE.

Sterlite Technologies has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bandhan Mutual Fund.

The above information is a part of company’s filings submitted to BSE.